SYSTEMIC LUPUS ERYTHEMATOSUS : CASE REPORT

Abstract

Systemic lupus erythematosus (systemic lupus erythematosus, SLE), an autoimmune
disease characterized by the production of antibodies against components of the cell
nucleus that is associated with a broad clinical manifestations. Ninety percent of cases
of systemic lupus erythematosus attacking a young woman with a peak incidence at 1540
years
of
age
during
the
reproductive
period
with
the
ratio
of
women
and
men
5:1.
Its

etiology

is unclear, allegedly associated with a specific immune response genes in the
major histocompatibility complex class II, HLA-DR2 and HLA DR3. Clinical
manifestations which appear heterogeneous and involve almost all organ systems of the
condition of the joints and skin of patients with mild to severe disease that attacks the
central nervous system, lungs, gastrointestinal tract, and kidneys. Treatment is mainly
aimed at controlling the symptoms of the acute attack and suppress symptoms and
weight at a level that can be tolerated and prevent organ damage.